Investors
Mauna Kea Technologies
Stock Information
Mauna Kea Technologies
Stock Information
Stay up to date on all our investor news
0,1550€
Last updated
30/07/2026 - 00:24
+1,84%
Events and
Presentations
Financial
Results
Governance
Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth
No results found.
MKT – Webinar – July 21, 2026
No results found.
Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity
No results found.
Mauna Kea Technologies Secures €4.0M Shareholder Loan Agreement to Strengthen Liquidity and Fund Organic Growth
No results found.
Voting Rights Information – June 2026
No results found.
News
Mauna Kea Technologies Announces Two New Peer-Reviewed Clinical Studies Confirming the Clinical Value of Cellvizio® and Its Combination with AI for the Diagnosis of Pancreatic Cysts
Mauna Kea Technologies Reports Strong H1 2026 Core Sales Growth
Mauna Kea Technologies to Host a Webinar on July 21, 2026 To Discuss Its First-Half Business Activity
No results found.
Shareholding Structure
Stock Information
STOCK MARKET DATA
Listed on Euronext Growth Paris
Initial listing : July 6, 2011
The number of outstanding shares is : 79,439,997
Industry : healthcare (4000)
Sector : Medical equipment and healthcare services (4530)
IDENTIFICATION CODES
ISIN : FR0010609263
Ticker : ALMKT
ANALYST COVERAGE
ALLINVEST SECURITIES
Thibaut Voglimacci – Stephanopoli
EUROLAND CORPORATE
EUROLAND CORPORATE
Raphaël Génin
STATUTORY AUDITORS
• EY and Others, represented by Mr Franck SEBAG, 1-2 place des Saisons, 92400 Courbevoie- Paris La Défense, France